drugset / Trial / NCT04904120
Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy
RandomizedCrossoverSingle-blindDiagnostic
Summary
The study hypothesis is that new imaging agents \[203Pb\]VMT01 and \[68Ga\]VMT02 can be safely used in humans without independent biological effect and can be used to image melanoma tumors expressing the melanocortin sub-type 1 receptor (MC1R) by SPECT/CT and PET/CT imaging modalities respectively.
Timeline
- Start
- 2021-03-05
- Primary completion
- 2022-09-20
- Completion
- 2022-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | [203Pb]VMT01 | Unknown | — | Intravenous |
| Comparator | [68Ga]VMT02 | Unknown | — | Intravenous |